Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
1.240
+0.080 (6.90%)
At close: Nov 7, 2025, 4:00 PM EST
1.270
+0.030 (2.42%)
After-hours: Nov 7, 2025, 5:33 PM EST
Talphera Revenue
Talphera had revenue of $27.00K in the twelve months ending June 30, 2025, down -93.22% year-over-year.
Revenue (ttm)
$27.00K
Revenue Growth
-93.22%
P/S Ratio
2,140.59
Revenue / Employee
$2,077
Employees
13
Market Cap
57.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 651.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 378.00K | -5.04M | -93.02% |
| Dec 31, 2020 | 5.42M | 3.13M | 136.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLPH News
- 3 days ago - Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025 - PRNewsWire
- 18 days ago - Talphera Announces the Appointment of Joe Todisco to Board of Directors - PRNewsWire
- 2 months ago - CorMedix Announces Strategic Minority Investment in Talphera - GlobeNewsWire
- 2 months ago - Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market - PRNewsWire
- 2 months ago - Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial - PRNewsWire
- 3 months ago - Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025 - PRNewsWire